Zentalis Pharmaceuticals slides after pricing23M share public offering
· seekingalpha.com
Zentalis Pharmaceuticals (ZNTL) announced the pricing of an underwritten public offering of 23M shares of its common stock at a public offering price of $3.50 per share. Gross proceeds from the offering are expected to be approximately $80.5M
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...